You are here

  • Home
  • Archive
  • Volume 96, Issue 9
  • Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study

Article info

Article menu
Download PDFPDF
Drug-induced cardiotoxicity
Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study

Authors

  1. Correspondence to Dr Emily Ho, Department of Cardiology, St. James's Hospital, Dublin 8, Ireland; emilyho28{at}gmail.com
View Full Text

Citation

Ho E, Brown A, Barrett P, et al
Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study
Heart 2010;96:701-707.

Publication history

  • Accepted January 18, 2010
  • First published April 27, 2010.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2010, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.